The main weakness of the present study may be that it was performed by comparing only two cases of proliferating and involuting hemangiomas, but it is the first report highlighting the divergent gene expression of AKT1, MAPK14, and ACTA2, and is not previously reported in involuting and proliferating infantile hemangiomas. This evidence concerns the gene ACTA2 and capillary hemangioma.